Metabolism of the monoamine oxidase-B inhibitor, MD 780236 and its enantiomers by the A and B forms of the enzyme in the rat
- 1 December 1983
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 35 (12) , 837-840
- https://doi.org/10.1111/j.2042-7158.1983.tb02911.x
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- The Metabolism of Dopamine by Both Forms of Monoamine Oxidase in the Rat Brain and Its Inhibition by CimoxatoneJournal of Neurochemistry, 1983
- A monoamine oxidase-B inhibitor, MD 780236, metabolized essentially by the A form of the enzyme in the ratJournal of Pharmacy and Pharmacology, 1983
- The enzyme-activated irreversible inhibition of type-B monoamine oxidase by 3-{4-[(3-chlorophenyl)methoxy]phenyl}-5-[(methylamino) methyl]-2-oxazolidinone methanesulphonate (compound MD 780236) and the enzyme-catalysed oxidation of this compound as competing reactionsBiochemical Journal, 1983
- Intestinal metabolism of tyramine by both forms of monoamine oxidase in the ratBiochemical Pharmacology, 1983
- In vitro metabolism in the rabbit of desipramine and nortriptyline to yield carboxylic acidsJournal of Pharmacy and Pharmacology, 1982
- Multiple forms of monoamine oxidase: Fact and artefactLife Sciences, 1976